Bellevue Group »

Alamar Biosciences shares owned by Bellevue Group

Quarter-by-quarter ownership of Alamar Biosciences shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Alamar Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Alamar Biosciences held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alamar Biosciences by Bellevue Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.5M 56k 27.09

More positions owned by Bellevue Group

Amgen (AMGN)
Vertex Pharmaceuticals Incorporated (VRTX)
Argenx Se Sponsored Adr (ARGX)
Gilead Sciences (GILD)
Revolution Medicines (RVMD)
Oruka Therapeutics (ORKA)
Insmed Com Par $.01 (INSM)
Scholar Rock Hldg Corp (SRRK)
Nuvalent Inc-a (NUVL)
Miragen Therapeutics (VRDN)
Relay Therapeutics (RLAY)
Vaxcyte (PCVX)
United Therapeutics Corporation (UTHR)
Intuitive Surgical Com New (ISRG)
Regeneron Pharmaceuticals (REGN)

View all positions for Bellevue Group

Top funds holding Alamar Biosciences

Sands Capital Ventures
Samsara BioCapital
ARK Investment Management
Braidwell
Alliancebernstein
Hillhouse Capital Advisors
BlackRock
Millennium Management
FMR
Pura Vida Investments
Emerald Advisers
Artisan Partners Limited Partnership
Deerfield Management Company
Vanguard Capital Management
Farallon Capital Management

View all funds holding Alamar Biosciences